An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
| Status: | Withdrawn |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/24/2017 |
| Start Date: | October 31, 2017 |
| End Date: | November 1, 2018 |
A Phase 2, Non-controlled, Open-Label, Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
The purpose of this study is to investigate the effect of BPS804 on strength/quality of bone
in patients with Type I, III or IV Osteogenesis imperfecta using a special type of CT
scanner. Participants will be treated for 1 year.
in patients with Type I, III or IV Osteogenesis imperfecta using a special type of CT
scanner. Participants will be treated for 1 year.
Inclusion Criteria:
- Patients with a clinical diagnosis of OI Type I, III or IV
- Capable of giving signed consent
Exclusion Criteria:
- History of skeletal malignancies or other bone diseases (other than OI)
- History of endocrine or thyroid/parathyroid conditions that could affect bone
metabolism
- Treatment with bisphosphonates within 3 months of randomisation
- Treatment with teraparatide, denosomab or other anabolic/antiresorbative medications
within 6 months of randomisation
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials